Companies/US/SILO

SILO PHARMA, INC.

Last · NasdaqCM$1.20-0.02 (-1.64%)close · yahoo · 17h ago
Vol 64.8K ≈ 77.8K
Market cap$2.46M2.1M sh
P/E · TTM-0.3fwd -1.7 · eps -4.21 · loss
Beta0.91vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.10$10.43
Volume64.8Ksession

Issuer

Legal nameSILO PHARMA, INC.
HQUnited States (US)
ListingUS SILO
ISINUS82711P3001
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001514183
CIK0001514183
Websitewww.silopharma.com
Employees3
AddressSilo Pharma, Inc. 677 North Washington Boulevard 34236, Sarasota
Loading chart…

Press & signals

2 recent
  • GlobeNewswire

    Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio

  • GlobeNewswire

    Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform

Documents

FormReporting forFiledFlags
8-K8-K: Entry into a Material Definitive Agreement
2026-10-132026-10-140
8-KCurrent Report (8-K)
—2026-10-020
8-K8-K: Entry into a Material Definitive Agreement
2026-08-182026-08-190
8-K8-K: Amendments to Articles of Incorporation or Bylaws
2026-08-142026-08-170
10-Q
2026-06-302026-08-13 7
Showing 5 of 23 filings